Get startedLog in
    Picture of Swedish Orphan Biovitrum AB (publ) logo

    SOBI — Swedish Orphan Biovitrum AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: SOBI Receives Health Canada Approval For Empaveli® (Pegcetacoplan) For The Treatment Of C3g And Primary IC-Mpgn

    Picture of Swedish Orphan Biovitrum AB (publ) logoSwedish Orphan Biovitrum AB (publ)
    09/04/2026 23:09
    April 9 (Reuters) - Swedish Orphan Biovitrum AB (publ) SOBIV.ST:

SOBI RECEIVES HEALTH CANADA APPROVAL FOR EMPAVELI® (PEGCETACOPLAN) FOR THE TREATMENT OF C3G AND PRIMARY IC-MPGN

Source text: ID:nGNXbvR39w

Further company coverage: SOBIV.ST

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Swedish Orphan Biovitrum AB (publ)

    See all news